Skip to main content
Premium Trial:

Request an Annual Quote

Alveo Technologies: Julianne Averill

Infectious disease diagnostic firm Alveo Technologies recently announced the appointment of Julianne Averill as CFO. She will be responsible for leading all financial operations and implementing strategies to accelerate Alveo's growth, the company said in a statement. Averill has 18 years of leadership experience and most recently served as VP of Finance for BlackThorn Therapeutics. Before that, she held leadership positions at Manifest MedEx and Starwood Waypoint Residential Trust and served as an audit manager at Deloitte. Averill has also participated in or led strategic financing and M&A initiatives totaling more than $2 billion. 

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.